Showing 1 - 4 results of 4 for search 'A. Shimoni', query time: 0.03s Refine Results
  1. 1
    Best practices for collecting repeated measures data using text messages

    Best practices for collecting repeated measures data using text messages by Noa’a Shimoni, Siripanth Nippita, Paula M. Castaño

    Published 2020-01-01
    Get full text
    Article
  2. 2
    PB1809: CLINICAL TRAJECTORY OF LONG-TERM SURVIVORS OF ACUTE MYELOID LEUKEMIA TREATED WITH INTENSIVE INDUCTION CHEMOTHERAPY

    PB1809: CLINICAL TRAJECTORY OF LONG-TERM SURVIVORS OF ACUTE MYELOID LEUKEMIA TREATED WITH INTENSIVE INDUCTION CHEMOTHERAPY by G. Heering, M. Sasson, D. Dominissini, A. Shimoni, A. Avigdor, A. Nagler, J. Canaani

    Published 2022-06-01
    Get full text
    Article
  3. 3
    P1108: HIGH COMPLETE RESPONSE RATE FOLLOWING POINT-OF-CARE ANTI CD19 CAR T-CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA

    P1108: HIGH COMPLETE RESPONSE RATE FOLLOWING POINT-OF-CARE ANTI CD19 CAR T-CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA by S. Fried, M. J. Besser, E. Shkury, R. Yerushalmi, N. Shem-Tov, I. Danylesko, E. Jacoby, O. Itzhaki, R. Shouval, M. Kedmi, A. Shimoni, A. Nagler, A. Avigdor

    Published 2022-06-01
    Get full text
    Article
  4. 4
    P1371: GRAFT-VERSUS-HOST DISEASE OFFERS NO GRAFT-VERSUS-LEUKEMIA ADVANTAGE IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AFTER HAPLO-IDENTICAL STEM CELL TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE

    P1371: GRAFT-VERSUS-HOST DISEASE OFFERS NO GRAFT-VERSUS-LEUKEMIA ADVANTAGE IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AFTER HAPLO-IDENTICAL STEM CELL TRANSPLANTATION WITH POST-T... by A. Shimoni, C. Peczynski, M. Labopin, E. Angelucci, Y. Koc, M. Arat, J. Tischer, S. Sica, Z. Gülbas, G. Socié, D. Blaise, P. Pioltelli, H. Ozdogu, J. Vydra, F. Ciceri, A. Nagler, M. Mohty

    Published 2022-06-01
    Get full text
    Article

Search Tools: